[Story ID: 243]
/PRNewswire-Asia-FirstCall/ — Recon Technology, Ltd. (Nasdaq: RCON), a leading Chinese non-state-owned oil and gas automation services provider, said today that its financial results for its FY …
[Story ID: 240]
The Association for Molecular Pathology (AMP) commends the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS) for its thoughtful, deliberative exploration into the challenges of gene patents .
[Story ID: 244]
Recon Technology, Ltd. , a leading Chinese non-state-owned oil and gas automation services provider, said today that its financial results for its FY ‘10 second quarter ended December 31, 2009 will be released on Thursday February 11, 2010.
[Story ID: 241]
The Health and Human Service’s Secretary’s Advisory Committee on Genetics, Health and Society is expected to release six recommendations concerning gene patents , reports Science Insider.
[Story ID: 245]
Our guest speaker, Anne Miller is Director of The Creativity Partnership ( www.tcp-uk.co.uk ), author of How to get your ideas adopted (and change the world) and a co-founder of the successful technology innovation organisation TTP Group.
[Story ID: 242]
Bradley Kuhn, the technology director of the Software Freedom Law Center (SFLC) expressed dismay this week after learning that Black Duck Software was granted a patent that covers software methods for detecting and resolving open source software licensing conflicts. Kuhn, who plays a major role in the SFLC’s GPL enforcement efforts, contends that [...]
[Story ID: 217]
USA Today’s On Politics: Sen. Mary Landrieu, D-La., took to the Senate floor Thursday “to defend the so-called ‘Louisiana purchase.’” Describing the deal as a “‘bipartisan effort,’” she said she made no apologies for leading the push to cut a deal “to get Louisiana $300 million in extra Medicaid funds inserted into the [...]
[Story ID: 218]
The American Academy of Orthopaedic Surgeons (AAOS) recently approved and released an evidence-based clinical practice guideline on the Treatment of Distal Radius Fractures.
[Story ID: 219]
Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart’
[Story ID: 220]
Conventional hepatectomy is an effective way to treat hepatocellular carcinoma (HCC). However, it is invasive and stressful. Laparoscopic surgery, a kind of minimally invasive surgery, has recently gained considerable advances.